FMR LLC & Abigail Johnson Hold 15% Stake in Ionis Pharma
Ticker: IONS · Form: SC 13G/A · Filed: Feb 9, 2024 · CIK: 874015
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**FMR LLC and Abigail Johnson still own 15% of Ionis Pharma, showing strong conviction.**
AI Summary
FMR LLC, a major investment firm, and its CEO, Abigail P. Johnson, have updated their ownership stake in IONIS PHARMACEUTICALS INC. As of February 9, 2024, they collectively beneficially own 21,520,872 shares of common stock, representing 15.000% of the company. This filing, an amendment to a previous Schedule 13G, indicates a significant, but not necessarily new, long-term investment by a prominent institutional holder, which can signal confidence in the company's future to current and prospective shareholders.
Why It Matters
This filing shows a major institutional investor, FMR LLC, and its principal, Abigail P. Johnson, maintain a substantial 15.000% ownership in IONIS PHARMACEUTICALS INC, which can be a positive signal of long-term confidence for other investors.
Risk Assessment
Risk Level: low — This filing indicates a stable, significant institutional ownership, which generally reduces volatility and provides a vote of confidence in the company.
Analyst Insight
A smart investor would note the continued significant institutional ownership by FMR LLC as a potential sign of long-term stability and confidence in IONIS PHARMACEUTICALS INC, but should still conduct their own due diligence on the company's fundamentals and future prospects.
Key Numbers
- 21,520,872 — Shares Beneficially Owned (Represents the total number of common stock shares of IONIS PHARMACEUTICALS INC held by FMR LLC and Abigail P. Johnson.)
- 15.000% — Percent of Class (Indicates the significant proportion of IONIS PHARMACEUTICALS INC's common stock owned by FMR LLC and Abigail P. Johnson.)
Key Players & Entities
- FMR LLC (company) — reporting person and parent holding company
- Abigail P. Johnson (person) — reporting person, associated with FMR LLC
- IONIS PHARMACEUTICALS INC (company) — the issuer of the securities
- 21,520,872 (dollar_amount) — total shares beneficially owned
- 15.000% (dollar_amount) — percentage of class owned
Forward-Looking Statements
- FMR LLC will maintain a significant ownership stake in IONIS PHARMACEUTICALS INC. (FMR LLC) — high confidence, target: 2025-02-09
FAQ
Who are the primary reporting persons in this SC 13G/A filing?
The primary reporting persons are FMR LLC and Abigail P. Johnson, as stated in Item 1 for each reporting person.
What is the total number of shares of IONIS PHARMACEUTICALS INC common stock beneficially owned by the reporting persons?
The reporting persons, FMR LLC and Abigail P. Johnson, beneficially own a total of 21,520,872 shares of IONIS PHARMACEUTICALS INC common stock, as indicated in Item 7 for both FMR LLC and Abigail P. Johnson, and Item 4(a) for FMR LLC.
What percentage of IONIS PHARMACEUTICALS INC's common stock do the reporting persons collectively own?
FMR LLC and Abigail P. Johnson collectively own 15.000% of the class of IONIS PHARMACEUTICALS INC's common stock, as specified in Item 11 for both reporting persons and Item 4(b) for FMR LLC.
What is the CUSIP number for IONIS PHARMACEUTICALS INC common stock mentioned in the filing?
The CUSIP number for IONIS PHARMACEUTICALS INC common stock is #462222100, as stated at the beginning of the Schedule 13G and in Item 2(e).
Under which rule is this Schedule 13G/A filed?
This Schedule 13G/A is filed pursuant to Rule 13d-1(b), as indicated by the checked box in the filing and further explained in Item 3.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on February 9, 2024 by Abigail P. Johnson regarding IONIS PHARMACEUTICALS INC (IONS).